Medpace Holdings, Inc. Files 8-K with Corporate Updates
Ticker: MEDP · Form: 8-K · Filed: May 21, 2024 · CIK: 1668397
| Field | Detail |
|---|---|
| Company | Medpace Holdings, Inc. (MEDP) |
| Form Type | 8-K |
| Filed Date | May 21, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, regulatory
Related Tickers: MPD
TL;DR
Medpace filed an 8-K on May 17th covering corporate changes and shareholder votes.
AI Summary
Medpace Holdings, Inc. filed an 8-K on May 21, 2024, reporting events that occurred on May 17, 2024. The filing indicates changes to the company's articles of incorporation or bylaws, submission of matters to a vote of security holders, and the filing of financial statements and exhibits. Specific details regarding these events, including any financial implications or voting outcomes, are not elaborated upon in this summary section of the filing.
Why It Matters
This 8-K filing signals important corporate governance and operational updates for Medpace Holdings, Inc., which could affect its structure, shareholder decisions, and financial reporting.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain immediate negative financial news or significant strategic shifts.
Key Players & Entities
- Medpace Holdings, Inc. (company) — Registrant
- May 17, 2024 (date) — Earliest event reported
- May 21, 2024 (date) — Date of report
- 5375 Medpace Way, Cincinnati, Ohio 45227 (address) — Principal Executive Offices
FAQ
What specific amendments were made to Medpace Holdings, Inc.'s articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary section of the 8-K.
What matters were submitted to a vote of Medpace Holdings, Inc. security holders?
The filing confirms that matters were submitted to a vote, but the nature of these matters is not specified in this section.
What financial statements and exhibits are being filed with this 8-K?
The filing states that financial statements and exhibits are included, but their specific content is not detailed here.
What is the principal business address of Medpace Holdings, Inc.?
The principal executive offices of Medpace Holdings, Inc. are located at 5375 Medpace Way, Cincinnati, Ohio 45227.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 17, 2024.
Filing Stats: 922 words · 4 min read · ~3 pages · Grade level 12.5 · Accepted 2024-05-21 16:05:59
Key Financial Figures
- $0.01 — hange on which registered Common Stock $0.01 par value MEDP Nasdaq Global Select
Filing Documents
- d821074d8k.htm (8-K) — 41KB
- d821074dex31.htm (EX-3.1) — 33KB
- d821074dex32.htm (EX-3.2) — 127KB
- 0001193125-24-143907.txt ( ) — 360KB
- medp-20240517.xsd (EX-101.SCH) — 3KB
- medp-20240517_lab.xml (EX-101.LAB) — 18KB
- medp-20240517_pre.xml (EX-101.PRE) — 11KB
- d821074d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits No. Description 3.1 Restated Certificate of Incorporation 3.2 Second Amended and Restated Bylaws 104 Cover Page Interactive Data File—the cover page XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MEDPACE HOLDINGS, INC. Date: May 21, 2024 By: /s/ Stephen P. Ewald Name: Stephen P. Ewald Title: General Counsel and Corporate Secretary